HCA Healthcare Inc Q4 2021 Earnings Call Summary - Thomson StreetEvents

HCA Healthcare Inc Q4 2021 Earnings Call Summary

HCA Healthcare Inc Q4 2021 Earnings Call Summary - Thomson StreetEvents
HCA Healthcare Inc Q4 2021 Earnings Call Summary
Published Jan 27, 2022
19 pages (10545 words) — Published Jan 27, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Brief of HCA.N earnings conference call or presentation 27-Jan-22 3:00pm GMT

  
Brief Excerpt:

...A. Highlights: Reflecting on 2021, across many dimensions of business, teams demonstrated ability to adjust quickly and effectively to three different surges and deliver for patients, communities and each other. 1. 2. In 4Q21, COVID pandemic once again altered course with Omicron variant. As Delta variant surge was slowing down at 3Q21-end with some spillover into 4Q21, Omicron surge started to influence business in early Dec. a. b. Overall, teams continued their tremendous response and effects of pandemic's ever changing conditions were managed well as reflected in financial results for 4Q21, which were solid and in line with most recent guidance. 3. Hospitals provided care to 27,000 COVID-19 patients, approx. 5% of total admissions. Significantly below 3Q21's 13%. a. b. Since beginning of pandemic, provided inpatient care to over 260,000 patients, who contracted virus. c. Currently, hospitals continue to treat many patients with COVID-19. i. COVID-related census levels fortunately have...

  
Report Type:

Brief

Source:
Thomson StreetEvents
Company:
HCA Healthcare Inc
Ticker
HCA.N
Time
3:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Andrew Mok - UBS Investment Bank, Research Division - Analyst : I just wanted to echo congratulations to Mark on your retirement. On the 2022 guide, I want to make sure I understand the progression and development of the guide since the 3Q earnings call. Are you saying that since 3Q, you're now expecting more COVID patients? And because government relief only gives us line of sight through April, you're planning for a significantly higher level of COVID costs in 2022 but only 1 quarter of extended government relief, such that there's somewhat of a mismatch in COVID costs and COVID relief in 2022?

Question: Calvin Alexander Sternick - JPMorgan Chase & Co, Research Division - Analyst : I just wanted to circle back to some of the Medicaid comments you made, specifically related to rate determinations. Just want to understand what's assumed in your guys' guidance with respect to the resumption of Medicaid rate determinations and whether or not you think that has a discernible impact on your numbers, particularly in the back half.

Table Of Contents

HCA Healthcare Inc Q1 2022 Earnings Call Summary – 2022-04-22 – US$ 54.00 – Edited Brief of HCA.N earnings conference call or presentation 22-Apr-22 2:00pm GMT

HCA Healthcare Inc at Oppenheimer Healthcare Conference (Virtual) Transcript – 2022-03-15 – US$ 54.00 – Edited Transcript of HCA.N presentation 15-Mar-22 2:00pm GMT

HCA Healthcare Inc at Cowen Health Care Conference (Virtual) Transcript – 2022-03-09 – US$ 54.00 – Edited Transcript of HCA.N presentation 9-Mar-22 4:10pm GMT

HCA Healthcare Inc at SVB Leerink Global Healthcare (Virtual) Transcript – 2022-02-16 – US$ 54.00 – Edited Transcript of HCA.N presentation 16-Feb-22 3:40pm GMT

HCA Healthcare Inc Q4 2021 Earnings Call Transcript – 2022-01-27 – US$ 54.00 – Edited Transcript of HCA.N earnings conference call or presentation 27-Jan-22 3:00pm GMT

HCA Healthcare Inc at Wolfe Research Healthcare Conference (Virtual) Transcript – 2021-11-18 – US$ 54.00 – Edited Transcript of HCA.N presentation 18-Nov-21 2:50pm GMT

HCA Healthcare Inc Q3 2021 Earnings Call Summary – 2021-10-22 – US$ 54.00 – Edited Brief of HCA.N earnings conference call or presentation 22-Oct-21 2:00pm GMT

HCA Healthcare Inc Q3 2021 Earnings Call Transcript – 2021-10-22 – US$ 54.00 – Edited Transcript of HCA.N earnings conference call or presentation 22-Oct-21 2:00pm GMT

HCA Healthcare Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of HCA.N presentation 9-Sep-21 2:15pm GMT

HCA Healthcare Inc Q2 2021 Earnings Call Summary – 2021-07-20 – US$ 54.00 – Edited Brief of HCA.N earnings conference call or presentation 20-Jul-21 2:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "HCA Healthcare Inc Q4 2021 Earnings Call Summary" Jan 27, 2022. Alacra Store. May 22, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-HCA-Healthcare-Inc-Earnings-Call-B15089743>
  
APA:
Thomson StreetEvents. (2022). HCA Healthcare Inc Q4 2021 Earnings Call Summary Jan 27, 2022. New York, NY: Alacra Store. Retrieved May 22, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-HCA-Healthcare-Inc-Earnings-Call-B15089743>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.